CLASS II ONGOING Drug recall · Reported 8 Jan 2025 · FDA Enforcement Report

Dapsone Gel recalled by Viona Pharmaceuticals

Viona Pharmaceuticals is recalling Dapsone Gel 7.5%, distributed nationwide in the US. The recall was initiated on 10 Dec 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.
NDC72578-094
Quantity recalled23304 packs

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0171-2025
FDA event ID
95930
Recalling firm
Viona Pharmaceuticals, Cranford, NJ
Brand
Dapsone
Manufacturer
Viona Pharmaceuticals Inc
Classification
Class II
Status
Ongoing
Recall initiated
10 Dec 2024
FDA classified
2 Jan 2025
Reported
8 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

10 Dec 2024Recall initiated by company
2 Jan 2025Classified by FDA+23 days
8 Jan 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Crystallization

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Crystallization

Which lots are affected?

Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.

Where was it sold?

US Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 95930

This product is part of a recall event; the main page for the event is Dapsone Gel recalled by Viona Pharmaceuticals.

ReportedClassRecallCompanyReasonWhere
CLASS IIDapsone Gel recalled by Viona PharmaceuticalsDapsoneViona PharmaceuticalsPackaging DefectsNationwide

More recalls from Viona Pharmaceuticals

All 8

Other Dapsone recalls

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDapsone Gel recalled by Viona PharmaceuticalsDapsoneViona PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIDapsone Gel 7.5% pump recalled by Viona PharmaceuticalsDapsoneViona PharmaceuticalsOtherNationwide
DrugCLASS IIDapsone Gel 7.5% pump recalled by Viona PharmaceuticalsDapsoneViona PharmaceuticalsOtherNY